Molecular Matrix, a privately held company that arose from the University of California, Davis, received FDA approval for its Osteo-P bone graft substitute technology. Osteo-P is a non-mineralized, ...
Cerapedics Inc., a global, commercial-stage orthopedics company dedicated to redefining the path to bone repair, today ...
A 24-month study of Cerapedics’ PearlMatrix P-15 peptide enhanced bone graft found it had better time-to-fusion and clinical success than a local autograft, according to a Dec. 17 news release. Five ...
Each year, about 2.2 million bone-grafting procedures are performed worldwide, the gold standard of care being autografting, which uses the patient's own bone for tooth implantation and to repair and ...
Researchers at Swansea University have created an innovative bone graft substitute inspired by coral. The study, published in the journal Bioactive Materials, accelerates healing and naturally ...
BURLINGTON, Mass.--(BUSINESS WIRE)--Bone Biologics Corporation (“Bone Biologics” or the “Company”) (Nasdaq: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets, announces that ...
A recent review is transforming the landscape of craniomaxillofacial bone regeneration with the introduction of personalized bioceramic grafts. This pioneering research explores the fabrication and ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. A novel synthetic bone graft showed noninferiority to ...
A glue-gun-like device that can be used to print biodegradable bone grafts directly into fractures could revolutionize orthopedic surgery, offering personalized implants that speed healing and cut ...
Cerapedics Inc., a global, commercial-stage orthopedics company dedicated to redefining the path to bone repair, today announced the publication of two back-to-back papers in Spine detailing 24-month ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback